|
EP2934532B1
(en)
|
2012-12-20 |
2019-10-23 |
Purdue Research Foundation |
Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics
|
|
SG11201505858VA
(en)
|
2013-01-28 |
2015-09-29 |
St Jude Childrens Res Hospital |
A chimeric receptor with nkg2d specificity for use in cell therapy against cancer and infectious disease
|
|
WO2014130635A1
(en)
|
2013-02-20 |
2014-08-28 |
Novartis Ag |
Effective targeting of primary human leukemia using anti-cd123 chimeric antigen receptor engineered t cells
|
|
US9657105B2
(en)
|
2013-03-15 |
2017-05-23 |
City Of Hope |
CD123-specific chimeric antigen receptor redirected T cells and methods of their use
|
|
NZ759969A
(en)
|
2013-12-20 |
2022-12-23 |
Fred Hutchinson Cancer Center |
Tagged chimeric effector molecules and receptors thereof
|
|
CN107074957B
(zh)
|
2014-01-13 |
2021-05-07 |
希望之城公司 |
在Fc间隔物区中具有突变的嵌合抗原受体(CAR)及其使用方法
|
|
SG10201808811QA
(en)
|
2014-04-10 |
2018-11-29 |
Seattle Childrens Hospital Dba Seattle Childrens Res Inst |
Method and compositions for cellular immunotherapy
|
|
EP3805371A1
(en)
|
2014-05-15 |
2021-04-14 |
National University of Singapore |
Modified natural killer cells and uses thereof
|
|
EP3712171A1
(en)
|
2014-08-19 |
2020-09-23 |
Novartis AG |
Treatment of cancer using a cd123 chimeric antigen receptor
|
|
ES2738705T3
(es)
*
|
2014-09-19 |
2020-01-24 |
Hope City |
Linfocitos T de receptor de antígeno quimérico coestimulante que se dirigen a IL13R 2
|
|
CN107429253B
(zh)
|
2014-12-05 |
2021-11-05 |
希望之城公司 |
Cs1靶向性嵌合抗原受体修饰的t细胞
|
|
AU2015357535B2
(en)
|
2014-12-05 |
2020-05-14 |
Eureka Therapeutics, Inc. |
Antibodies targeting G-protein coupled receptor and methods of use
|
|
WO2016100232A1
(en)
|
2014-12-15 |
2016-06-23 |
The Regents Of The University Of California |
Bispecific or-gate chimeric antigen receptor responsive to cd19 and cd20
|
|
EP3234120B1
(en)
|
2014-12-15 |
2025-09-03 |
The Regents of the University of California |
Cytotoxic molecules responsive to intracellular ligands for selective t cell mediated killing
|
|
GB201504840D0
(en)
|
2015-03-23 |
2015-05-06 |
Ucl Business Plc |
Chimeric antigen receptor
|
|
CN107849560B
(zh)
*
|
2015-04-27 |
2021-10-22 |
阿布维特罗有限责任公司 |
对治疗剂和疾病特异性抗原进行测序、确定、配对和验证的方法
|
|
EP3288570A4
(en)
|
2015-04-29 |
2018-11-21 |
Fred Hutchinson Cancer Research Center |
Modified stem cells and uses thereof
|
|
CN107849102B
(zh)
|
2015-05-15 |
2022-05-13 |
希望之城 |
嵌合抗原受体组合物
|
|
MX2018001568A
(es)
|
2015-08-07 |
2019-04-25 |
Seattle Children´S Hospital Dba Seattle Children´S Res Institute |
Celulas t biespecificas de receptor quimerico de antigeno (car) para focalizacion a tumores solidos.
|
|
EP4014996A1
(en)
|
2015-08-31 |
2022-06-22 |
Helixmith Co., Ltd |
Anti-sialyl tn chimeric antigen receptors
|
|
EP3747462A1
(en)
*
|
2015-10-06 |
2020-12-09 |
City of Hope |
Chimeric antigen receptors targeted to psca
|
|
JP7085990B2
(ja)
|
2015-10-13 |
2022-06-17 |
シティ・オブ・ホープ |
クロロトキシンドメインを含むキメラ抗原レセプター
|
|
WO2017075147A1
(en)
|
2015-10-27 |
2017-05-04 |
Board Of Regents, The University Of Texas System |
Chimeric antigen receptor molecules and uses thereof
|
|
EP3368571B1
(en)
|
2015-10-30 |
2022-12-07 |
The Regents of The University of California |
Transforming growth factor-beta-responsive polypeptides and their methods for use
|
|
ES2909973T3
(es)
*
|
2015-11-04 |
2022-05-10 |
Hope City |
Receptores quiméricos para el antígeno que se dirigen a HER2
|
|
JP7189019B2
(ja)
*
|
2016-02-05 |
2022-12-13 |
シティ・オブ・ホープ |
中枢神経系の癌の治療のための操作されたｔ細胞の投与
|
|
WO2017172952A1
(en)
*
|
2016-04-01 |
2017-10-05 |
Promab Biotechnologies, Inc. |
Flag tagged cd19-car-t cells
|
|
CA3019835A1
(en)
|
2016-04-08 |
2017-10-12 |
Purdue Research Foundation |
Methods and compositions for car t cell therapy
|
|
CN118652336A
(zh)
|
2016-06-08 |
2024-09-17 |
普瑞赛格恩公司 |
Cd33特异性嵌合抗原受体
|
|
CN106117366A
(zh)
*
|
2016-06-24 |
2016-11-16 |
安徽未名细胞治疗有限公司 |
一种cd19特异性嵌合抗原受体及其编码基因、应用
|
|
ES2960835T3
(es)
|
2016-07-12 |
2024-03-06 |
Kite Pharma Inc |
Moléculas de unión a antígeno y métodos de uso de las mismas
|
|
CA3039136A1
(en)
|
2016-09-02 |
2018-03-08 |
The Regents Of The University Of California |
Methods and compositions involving interleukin-6 receptor alpha-binding single chain variable fragments
|
|
EP3518944A4
(en)
*
|
2016-09-30 |
2020-06-17 |
Baylor College of Medicine |
ADAPTIVE CHIMERIC ANTIGENT RECEPTOR T-CELL DESIGN
|
|
WO2018075813A1
(en)
|
2016-10-19 |
2018-04-26 |
City Of Hope |
Use of endogenous viral vaccine in chimeric antigen receptor t cell therapy
|
|
WO2018111763A1
(en)
|
2016-12-12 |
2018-06-21 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Chimeric transcription factor variants with augmented sensitivity to drug ligand induction of transgene expression in mammalian cells
|
|
CN108395482B
(zh)
|
2017-02-08 |
2021-02-05 |
西比曼生物科技（香港）有限公司 |
一种靶向cd20抗原嵌合抗原受体的构建及其工程化t细胞的活性鉴定
|
|
MX2019011570A
(es)
|
2017-03-27 |
2019-11-18 |
Nat Univ Singapore |
Lineas celulares estimuladoras para expansion y activacion ex vivo de celulas asesinas naturales.
|
|
CN117363636A
(zh)
|
2017-03-27 |
2024-01-09 |
新加坡国立大学 |
一种编码嵌合受体的多核苷酸
|
|
PL3618842T3
(pl)
*
|
2017-05-01 |
2024-02-19 |
Juno Therapeutics, Inc. |
Kombinacja terapii komórkowej i związku immunomodulującego
|
|
CN111051349A
(zh)
*
|
2017-09-06 |
2020-04-21 |
弗雷德哈钦森癌症研究中心 |
Strep-tag特异性嵌合受体及其用途
|
|
EP3684803A1
(en)
|
2017-09-22 |
2020-07-29 |
Kite Pharma, Inc. |
Antigen binding molecules and methods of use thereof
|
|
US11066475B2
(en)
|
2017-11-01 |
2021-07-20 |
Juno Therapeutics, Inc. |
Chimeric antigen receptors specific for B-cell maturation antigen and encoding polynucleotides
|
|
US11851679B2
(en)
|
2017-11-01 |
2023-12-26 |
Juno Therapeutics, Inc. |
Method of assessing activity of recombinant antigen receptors
|
|
US20200345823A1
(en)
*
|
2017-11-07 |
2020-11-05 |
Xiuli Wang |
Treatment of cns lymphoma and systemic lymphoma with intracerebroventricularly administered cd19 car
|
|
CN109971717B
(zh)
*
|
2017-12-28 |
2023-06-20 |
上海细胞治疗研究院 |
共表达cd40抗体与间皮素特异性嵌合抗原受体的t细胞及其用途
|
|
CN109971714B
(zh)
*
|
2017-12-28 |
2023-06-20 |
上海细胞治疗研究院 |
自表达pd-1抗体并靶向间皮素的嵌合抗原受体修饰t细胞及其用途
|
|
CN109971723B
(zh)
*
|
2017-12-28 |
2023-07-07 |
上海细胞治疗研究院 |
包含CD40抗体与muc1特异性嵌合抗原受体基因的T细胞及其用途
|
|
CN109971721B
(zh)
*
|
2017-12-28 |
2023-10-31 |
上海细胞治疗研究院 |
自表达cd47抗体的间皮素特异性car-t细胞及其用途
|
|
CN109971712B
(zh)
*
|
2017-12-28 |
2023-06-20 |
上海细胞治疗研究院 |
特异性靶向cd19抗原且高水平稳定表达pd-1抗体的car-t细胞及用途
|
|
CN109971725B
(zh)
|
2017-12-28 |
2024-02-02 |
上海细胞治疗研究院 |
抗体修饰的嵌合抗原受体修饰t细胞及其用途
|
|
CN109971716B
(zh)
*
|
2017-12-28 |
2023-08-01 |
上海细胞治疗研究院 |
自分泌cd47抗体的egfr特异性car-t细胞及其用途
|
|
CN109971722B
(zh)
*
|
2017-12-28 |
2023-09-01 |
上海细胞治疗研究院 |
靶向cd19且高水平稳定表达cd40抗体的car-t细胞及其用途
|
|
WO2019144095A1
(en)
|
2018-01-22 |
2019-07-25 |
Seattle Children's Hospital (dba Seattle Children's Research Institute) |
Methods of use for car t cells
|
|
JP7360174B2
(ja)
|
2018-02-09 |
2023-10-12 |
ナショナル ユニヴァーシティー オブ シンガポール |
ナチュラルキラー細胞免疫療法における活性化キメラ受容体及びその使用
|
|
JP7568224B2
(ja)
|
2018-02-23 |
2024-10-16 |
エンドサイト・インコーポレイテッド |
Ｃａｒ ｔ細胞療法のための配列決定法
|
|
US20210079061A1
(en)
*
|
2018-02-26 |
2021-03-18 |
Fred Hutchinson Cancer Research Center |
Compositions and methods for cellular immunotherapy
|
|
US12441787B2
(en)
|
2018-04-02 |
2025-10-14 |
National University Of Singapore |
Neutralization of human cytokines with membrane-bound anti-cytokine non-signaling binders expressed in immune cells
|
|
CA3103610A1
(en)
*
|
2018-06-12 |
2019-12-19 |
The Regents Of The University Of California |
Single-chain bispecific chimeric antigen receptors for the treatment of cancer
|
|
MX2021000617A
(es)
*
|
2018-07-18 |
2021-04-13 |
Amgen Inc |
Receptores quimericos de steap1 y metodos de uso de los mismos.
|
|
WO2020044239A1
(en)
|
2018-08-29 |
2020-03-05 |
National University Of Singapore |
A method to specifically stimulate survival and expansion of genetically-modified immune cells
|
|
ES3068417T3
(en)
*
|
2018-09-13 |
2026-05-29 |
Nkarta Inc |
Natural killer cell compositions and immunotherapy methods for treating a liver tumor
|
|
CN109096405B
(zh)
*
|
2018-09-20 |
2021-07-09 |
杭州普略生物科技有限公司 |
以gd2为靶点的嵌合抗原受体及药物组合物
|
|
CN116121302A
(zh)
*
|
2018-09-27 |
2023-05-16 |
公益财团法人实验动物中央研究所 |
免疫缺陷小鼠
|
|
US12473345B2
(en)
|
2018-11-01 |
2025-11-18 |
Juno Therapeutics, Inc. |
Methods for treatment using chimeric antigen receptors specific for B-cell maturation antigen
|
|
CN113573719A
(zh)
|
2018-11-08 |
2021-10-29 |
朱诺治疗学股份有限公司 |
治疗和t细胞调节的方法和组合
|
|
CN113226340A
(zh)
|
2018-11-26 |
2021-08-06 |
恩卡尔塔公司 |
同时扩增多种免疫细胞类型的方法、相关组合物及其在癌症免疫疗法中的用途
|
|
KR20210137085A
(ko)
|
2019-03-05 |
2021-11-17 |
엔카르타, 인크. |
Cd19 유도된 키메라 항원 수용체 및 면역 요법에서 이의 용도
|
|
CN113784733B
(zh)
*
|
2019-05-07 |
2024-09-06 |
亘喜生物科技（上海）有限公司 |
靶向bcma的工程化免疫细胞及其用途
|
|
EP4778585A2
(en)
*
|
2019-05-07 |
2026-07-22 |
Gracell Bioscience (Shanghai) Co., Ltd. |
Engineered immune cell targeting bcma and use thereof
|
|
US12702708B2
(en)
|
2019-08-21 |
2026-08-11 |
Innovative Cellular Therapeutics Holdings, Ltd. |
Presenting cell and use thereof in cell therapy
|
|
CN113402612A
(zh)
|
2020-03-17 |
2021-09-17 |
西比曼生物科技（香港）有限公司 |
靶向cd19和cd20的联合嵌合抗原受体及其应用
|
|
CN111499763A
(zh)
*
|
2020-03-31 |
2020-08-07 |
江苏省省级机关医院 |
一种靶向mage-a1的特异性全人源嵌合抗原受体及其应用
|
|
JP2023522330A
(ja)
*
|
2020-04-17 |
2023-05-30 |
シティ・オブ・ホープ |
Ｆｌｔ３陽性悪性腫瘍を処置するためのｆｌｔ３標的化キメラ抗原受容体改変細胞
|
|
CN115461361B
(zh)
*
|
2020-05-08 |
2025-03-14 |
玛希敦大学 |
嵌合抗原受体和携带该受体的经修饰的细胞
|
|
MX2022014203A
(es)
*
|
2020-05-12 |
2023-02-22 |
Lyell Immunopharma Inc |
Espaciadores de receptores de antígenos quiméricos (car).
|
|
JP2023541253A
(ja)
|
2020-09-10 |
2023-09-29 |
ムスタング バイオ，インコーポレイテッド |
癌標的のｃａｒ－ｔ細胞を含む併用療法と、それを癌治療に使用する方法
|
|
CN112111014A
(zh)
*
|
2020-09-22 |
2020-12-22 |
廖文强 |
一种抗氧化嵌合型抗原受体和免疫细胞
|
|
CN116848147A
(zh)
*
|
2020-11-20 |
2023-10-03 |
先声再明医药有限公司 |
Cd19人源化抗体及其应用
|
|
US11661459B2
(en)
|
2020-12-03 |
2023-05-30 |
Century Therapeutics, Inc. |
Artificial cell death polypeptide for chimeric antigen receptor and uses thereof
|
|
IL303269A
(en)
|
2020-12-03 |
2023-07-01 |
Century Therapeutics Inc |
Genetically engineered cells and uses thereof
|
|
CN116600820A
(zh)
*
|
2020-12-16 |
2023-08-15 |
奥赖恩公司 |
嵌合抗原受体(car)间隔子修饰增强car t细胞功能
|
|
TW202241935A
(zh)
|
2020-12-18 |
2022-11-01 |
美商世紀治療股份有限公司 |
具有可調適受體專一性之嵌合抗原受體系統
|
|
US20240082306A1
(en)
*
|
2021-02-03 |
2024-03-14 |
Bioheng Therapeutics Limited |
Novel chimeric antigen receptor and use thereof
|
|
JP2024514308A
(ja)
*
|
2021-03-30 |
2024-04-01 |
シティ・オブ・ホープ |
ＣＡＲ Ｔ細胞療法及びＩＦＮγ
|
|
EP4722239A3
(en)
*
|
2021-08-20 |
2026-07-15 |
Christopher E. Rudd |
Compositions and methods for anti-virus chimeric antigen receptor
|
|
CN115873126A
(zh)
*
|
2021-11-26 |
2023-03-31 |
深圳科兴药业有限公司 |
人生长激素融合蛋白及其制备和用途
|
|
CN117004604A
(zh)
*
|
2022-04-28 |
2023-11-07 |
南京北恒生物科技有限公司 |
一种ciita基因被敲除的工程化免疫细胞及其用途
|
|
CN119923410A
(zh)
|
2022-07-28 |
2025-05-02 |
莱蒂恩技术公司 |
用于治疗实体瘤的嵌合抗原受体治疗
|
|
CN116254230A
(zh)
*
|
2022-09-14 |
2023-06-13 |
卡瑞济(北京)生命科技有限公司 |
用于制备和扩增通用型人源化抗cd19 car-nk细胞的方法及其用途
|
|
CN117942275A
(zh)
*
|
2022-10-31 |
2024-04-30 |
康码（上海）生物科技有限公司 |
一种基于病毒阻断剂的洗手液及其应用
|
|
US20260191905A1
(en)
|
2022-12-01 |
2026-07-09 |
Modernatx, Inc. |
Gpc3-specific antibodies, binding domains, and related proteins and uses thereof
|
|
PE20260290A1
(es)
|
2023-03-31 |
2026-02-10 |
Abelzeta Inc |
Receptores de antigeno quimericos biespecificos dirigidos a cd20 y bcma
|
|
CN119101166A
(zh)
*
|
2023-06-08 |
2024-12-10 |
博生吉医药科技(苏州)有限公司 |
B7-H3嵌合抗原受体修饰的Vδ1 T细胞及其应用
|
|
EP4780945A1
(en)
*
|
2023-09-20 |
2026-07-29 |
Kure.AI, Inc. |
Methods and reagents to improve cell therapy with the creation of novel car-targeting mr1 protein
|